Pathogenesis of the insulin resistance syndrome (Syndrome X)

Clinical and Experimental Pharmacology and Physiology

Volumn 24, Issue 9-10, 1997, Pages 782-784

  Chisholm, Donald J ^a   Campbell, Lesley V ^a   Kraegen, Edward W ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

Central obesity; Exercise; Insulin resistance; Non insulin dependent diabetes mellitus; Syndrome X; Thiazolidine diones

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE TRANSPORTER; METFORMIN; OXIDOREDUCTASE;

CALORIC RESTRICTION; CONFERENCE PAPER; EXERCISE; GENETIC ANALYSIS; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; LIPID STORAGE; NONHUMAN; OBESITY; SYNDROME X; TWINS; WEIGHT REDUCTION;

EID: 0030930069     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1997.tb02132.x     Document Type: Conference Paper

References (29)

1. Shipp JC, Stone DB. Insulin resistance and insulin allergy. In: Fajan SS, Sussman KE (eds). Diabetes mellitus: Diagnosis and treatment. American Diabetes Association, New York. 1971; 173-9.
2. Kahn CR, Goldstein BJ, Reddy SS. Hereditary and acquired syndromes of insulin resistance. In: Pickup J, Williams G (eds). Textbook of diabetes. Blackwell Science, London. 1991; 276-85.
3. Chisholm DJ, Kraegen EW, Storlien H. The aetiology of non-insulin-dependent diabetes. In: Alberti KGMM, Krall LP (eds). The Diabetes Animal. Elsevier Science, Amsterdam. 1991; 48-61.
4. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-607.
5. Carey DG, Jenkins AB, Campbell LV, Freund J, Chisholm DJ. Abdominal fat and insulin resistance in normal and overweight women. Diabetes 1996; 45: 633-8.
6. Yamashita S, Nakamura T, Shimomura I et al. Insulin resistance and body fat distribution. Diabetes Care 1996; 19: 287-91.
7. Storlien LH, Jenkins AB, Chisholm DJ, Pascoe WS, Kraegen EW. Influence of dietary fat composition on development of insulin resistance in rats: Relationship to muscle triglyceride and omega-3 fatty acids in muscle phospholipid. Diabetes 1991; 40: 280-9.
8. Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle: Its role in insulin sensitivity and the metabolic disturbance of diabetes mellitus. Lancet 1963; i: 785-9.
9. Kraegen EW, Jenkins AB, Campbell LV. Insulin insensitivity in skeletal muscle. In: Marshall SM, Home PD (eds). The Diabetes Annual. Elsevier Science, Amsterdam. 1994; 135-55.
10. Schmitz-Peiffer C, Browne CL, Oakes ND et al. Alterations in the expression and cellular localization of protein kinase C isozymes epsilon and theta are associated with insulin resistance in skeletal muscle of the high-fat-fed rat. Diabetes 1997; 46: 169-78.
11. Hotamisligil GS, Peraldi P, Budavari A, Ellis R. White MF, Spiegelman BM. IRS-1 mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α and obesity-induced insulin resistance. Science 1996; 271: 665-7.
12. Zawadski JK, Bogardus C, Foley J. Insulin action in obese non-insulin-dependent diabetics and in their isolated adipocytes before and after weight loss. Diabetes 1987; 36: 227-36.
13. Markovic TP, Jenkins AB, Campbell LV et al. The site of adipose tissue loss is related to improved insulin sensitivity with weight reduction in obesity with and without NIDDM. Proc. Aust. Diabetes Soc. 1995; Abstract 10.
14. Kraegen EW, James DE, Storlien LH, Burleigh KM, Chisholm DJ. In vivo insulin resistance in individual peripheral tissues of the high fat ted rat: Assessment by euglycaemic clamp plus deoxyglucose administration. Diabetologia 1986; 29: 192-8.
15. Storlien LH, Kraegen EW, Jenkins AB, Chisholm DJ. Effects of sucrose versus starch diets on in vivo insulin action, thermogenesis and obesity in rats. Am. J. Clin. Nutr. 1988; 47: 420-7.
16. Borkman M, Chisholm DJ, Furler SM et al. Effects of fish oil supplementation on glucose and lipid metabolism in non-insulin-dependent diabetes. Diabetes 1989; 38: 1314-19.
17. Borkman M, Campbell LV, Chisholm DJ, Storlien LH. High carbohydrate low fat diets do not enhance insulin sensitivity in normal subjects. J. Clin. Endocrinol. Metab. 1991; 72: 432-7.
18. James DE, Kraegen EW, Chisholm DJ. Muscle glucose metabolism in exercising rats: Comparison with insulin stimulation. Am. J. Physiol. 1985; 248: E575-80.
19. James DE, Kraegen EW, Chisholm DJ. Effects of exercise training on in vivo insulin action in individual tissues of the rat. J. Clin. Invest. 1985; 76: 657-66.
20. Wake SA, Sowden JA, Storlien LH et al. Insulin-regulatable glucose transporter on RNA in rat muscle: Effects of exercise training and dietary manipulation. Diabetes 1991; 40: 275-9.
21. Matsuzawa Y, Tokunaga K, Fujioka S, Tarui S. Pathophysiology of visceral fat obesity. In: Otamura Y (ed.). Progress in Obesity Research. J Libbey, London. 1990; P309-12.
22. Taylor R, Ram P, Zimmet P et al. Physical activity and prevalence of diabetes in Melanesian and Indian men in Fiji. Diabetologia 1984; 27: 578-82.
23. Zimmet PZ. The pathogenesis and prevention of diabetes in adults. Diabetes Care 1995; 18: 1050-64.
24. Stumvell M, Nurjhan N, Perriello G, Dailey G, Gerich J. Metabolic effects of Metformin in non-insulin-dependent diabetes mellitus. N. Engl. J. Med. 1995; 333: 550-4.
25. McIntyre HD, Paterson CA, Ma A, Ravenscroft PJ, Bird DM, Cameron DP. Metformin increases insulin sensitivity and basal glucose clearance in type 2 (non-insulin-dependent) diabetes mellitus. Aust. N.Z. J. Med. 1991; 21: 714-19.
26. Lithell HO. Hyperinsulinemia, insulin resistance, and the treatment of hypertension. Am. J. Hypertens. 1996; 9: S150-4.
27. Saltiel AR, Olefsky JM. Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes 1996; 45: 1661-9.
28. Oakes ND, Kennedy CJ, Jenkins AB, Laybutt DR, Chisholm DJ, Kraegen EW. Effects of a new antidiabetic agent BRL 49653 on rat dietary models of normal and impaired insulin sensitivity: Evidence for an interrelationship between glucoregulatory actions and reduced lipid availability. Diabetes 1994; 43: 1203-10.
29. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Wilson TM, Kliewer SA. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPAR γ). J. Biol. Chem. 1996; 270: 12953-6.